Fennec Pharmaceuticals Inc.FENCNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average, strong compound growth.
Left:
||||
Year-over-year operating income growth rate
Latest
120.11%
↑ 1003% above average
Average (9y)
-13.30%
Historical baseline
Range
High:120.11%
Low:-142.11%
CAGR
+14.9%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | 120.11% |
| 2023 | 41.13% |
| 2022 | -27.08% |
| 2021 | 4.55% |
| 2020 | -34.36% |
| 2019 | -27.88% |
| 2018 | -49.75% |
| 2017 | -142.11% |
| 2016 | -51.90% |
| 2015 | 34.31% |